ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 237 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q1 2022. The put-call ratio across all filers is 2.14 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $335 | -16.5% | 9,404 | +8.2% | 0.02% | -21.9% |
Q2 2023 | $401 | +0.2% | 8,693 | -12.8% | 0.03% | +10.3% |
Q1 2023 | $400 | -17.0% | 9,964 | -4.2% | 0.03% | -27.5% |
Q4 2022 | $482 | -99.9% | 10,398 | +7.5% | 0.04% | +8.1% |
Q3 2022 | $401,000 | -23.5% | 9,673 | +10.2% | 0.04% | -21.3% |
Q2 2022 | $524,000 | +75.8% | 8,779 | +114.1% | 0.05% | +370.0% |
Q1 2022 | $298,000 | – | 4,101 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
First Light Asset Management, LLC | 441,159 | $39,788,000 | 2.62% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 103,100 | $9,286,000 | 2.24% |
Rock Springs Capital Management LP | 801,109 | $72,252,000 | 1.52% |
Avidity Partners Management LP | 455,000 | $41,036,000 | 0.91% |
Motley Fool Asset Management LLC | 134,357 | $12,118,000 | 0.79% |
FEDERATED HERMES, INC. | 3,987,032 | $359,590,000 | 0.68% |
EMERALD ADVISERS, LLC | 196,124 | $17,688,000 | 0.64% |
Ergoteles LLC | 128,100 | $11,553,000 | 0.42% |
Tekla Capital Management LLC | 140,726 | $12,692,000 | 0.41% |
Beck Bode, LLC | 14,990 | $1,352,000 | 0.38% |